Evidence map›Paper›PMID 34990409›Full record

Trial reportThe Journal of clinical investigation2022

Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans.

Allison D Oliva, Rupali Gupta, Khalil Issa, Ralph Abi Hachem, David W Jang, Sebastian A Wellford, E Ashley Moseman, Hiroaki Matsunami, Bradley J Goldstein

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Olfactory immunity: defending the neural-mucosal barrier.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Olfactory models as a platform for neuroscience research.Frontiers in cellular neuroscience · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Strategies to Develop Regenerative Medicine Approaches for Olfactory Disorders.Clinical and experimental otorhinolaryngology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Allison D OlivaDepartment of Head and Neck Surgery & Communication Sciences and.
Rupali GuptaDepartment of Head and Neck Surgery & Communication Sciences and.
Khalil IssaDepartment of Head and Neck Surgery & Communication Sciences and.
Ralph Abi HachemDepartment of Head and Neck Surgery & Communication Sciences and.
David W JangDepartment of Head and Neck Surgery & Communication Sciences and.
Sebastian A WellfordDepartment of Immunology.
E Ashley MosemanDepartment of Immunology.
Hiroaki MatsunamiDepartment of Molecular Genetics and Microbiology.
Bradley J GoldsteinDepartment of Head and Neck Surgery & Communication Sciences and.
Allen Institute for Brain Science · USDuke University · US

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Biogenesis of olfactory G protein-coupled receptorsR01DC016224 · NIDCD · DUKE UNIVERSITY · PI MATSUNAMI, HIROAKI · 2017 to 2021
$2.2M
Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector FunctionsR01NS121067 · NINDS · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2025
$2.0M
Single cell analysis of human olfactory mucosaR21DC018371 · NIDCD · DUKE UNIVERSITY · PI GOLDSTEIN, BRADLEY J · 2020 to 2021
$443k
NIAID NIH HHS T32 AI052077NIDCD NIH HHS R01 DC016224NIDCD NIH HHS R21 DC018371NINDS NIH HHS R01 NS121067Wellcome Trust
6 · The paper itself

Abstract

BACKGROUNDPresbyosmia, or aging-related olfactory loss, occurs in a majority of humans over age 65 years, yet remains poorly understood, with no specific treatment options. The olfactory epithelium (OE) is the peripheral organ for olfaction and is subject to acquired damage, suggesting a likely site of pathology in aging. Adult stem cells reconstitute the neuroepithelium in response to cell loss under normal conditions. In aged OE, patches of respiratory-like metaplasia have been observed histologically, consistent with a failure in normal neuroepithelial homeostasis.MethodsAccordingly, we have focused on identifying cellular and molecular changes in presbyosmic OE. The study combined psychophysical testing with olfactory mucosa biopsy analysis, single-cell RNA-Sequencing (scRNA-Seq), and culture studies.ResultsWe identified evidence for inflammation-associated changes in the OE stem cells of presbyosmic patients. The presbyosmic basal stem cells exhibited increased expression of genes involved in response to cytokines or stress or the regulation of proliferation and differentiation. Using a culture model, we found that cytokine exposure drove increased TP63, a transcription factor acting to prevent OE stem cell differentiation.ConclusionsOur data suggest aging-related inflammatory changes in OE stem cells may contribute to presbyosmia via the disruption of normal epithelial homeostasis. OE stem cells may represent a therapeutic target for restoration of olfaction.FundingNIH grants DC018371, NS121067, DC016224; Office of Physician-Scientist Development, Burroughs-Wellcome Fund Research Fellowship for Medical Students Award, Duke University School of Medicine.

Indexed as

Cell DifferentiationGene Expression RegulationAgedAged, 80 and overAgingEpithelial CellsFemaleHumansMaleMiddle AgedOlfaction DisordersOlfactory MucosaProspective StudiesStem CellsAdult stem cellsAgingNeuronal stem cellsNeuroscience

Identifiers

PMID34990409
PMCPMC8843745
OpenAlexW4226094956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.